Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
21
ANIP Quote, Financials, Valuation and Earnings
Last price:
$53.38
Seasonality move
:
15.88%
Day range:
$53.00 - $54.56
52-week range:
$52.00 - $70.81
Dividend yield:
0%
P/E ratio:
53.21x
P/S ratio:
1.86x
P/B ratio:
2.76x
Volume:
1M
Avg. volume:
302.8K
1-year change:
2.03%
Market cap:
$1.1B
Revenue:
$486.8M
EPS (TTM):
-$0.57
ANI Pharmaceuticals SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
ANIP
ANI Pharmaceuticals
|
05/10/2024 | 10-Q | 10-Q filing on 05/10/2024 | View Form |
|
ANIP
ANI Pharmaceuticals
|
11/08/2023 | 10-Q | 10-Q filing on 11/08/2023 | View Form |
|
ANIP
ANI Pharmaceuticals
|
08/09/2023 | 10-Q | 10-Q filing on 08/09/2023 | View Form |
|
ANIP
ANI Pharmaceuticals
|
05/08/2023 | 10-Q | 10-Q filing on 05/08/2023 | View Form |
|
ANIP
ANI Pharmaceuticals
|
11/09/2022 | 10-Q | 10-Q filing on 11/09/2022 | View Form |
|
ANIP
ANI Pharmaceuticals
|
08/08/2022 | 10-Q | 10-Q filing on 08/08/2022 | View Form |
|
ANIP
ANI Pharmaceuticals
|
05/10/2022 | 10-Q | 10-Q filing on 05/10/2022 | View Form |
|
ANIP
ANI Pharmaceuticals
|
11/01/2021 | 10-Q | 10-Q filing on 11/01/2021 | View Form |
|
ANIP
ANI Pharmaceuticals
|
08/06/2021 | 10-Q | 10-Q filing on 08/06/2021 | View Form |
|
ANIP
ANI Pharmaceuticals
|
05/07/2021 | 10-Q | 10-Q filing on 05/07/2021 | View Form |
|
ANIP
ANI Pharmaceuticals
|
11/05/2020 | 10-Q | 10-Q filing on 11/05/2020 | View Form |
|
ANIP
ANI Pharmaceuticals
|
08/06/2020 | 10-Q | 10-Q filing on 08/06/2020 | View Form |
|
ANIP
ANI Pharmaceuticals
|
05/07/2020 | 10-Q | 10-Q filing on 05/07/2020 | View Form |
|
ANIP
ANI Pharmaceuticals
|
02/27/2020 | 10-K | 10-K filing on 02/27/2020 | View Form |
|
ANIP
ANI Pharmaceuticals
|
11/06/2019 | 10-Q | 10-Q filing on 11/06/2019 | View Form |
|
ANIP
ANI Pharmaceuticals
|
08/07/2019 | 10-Q | 10-Q filing on 08/07/2019 | View Form |
|
ANIP
ANI Pharmaceuticals
|
05/09/2019 | 10-Q | 10-Q filing on 05/09/2019 | View Form |
|
ANIP
ANI Pharmaceuticals
|
02/27/2019 | 10-K | 10-K filing on 02/27/2019 | View Form |
|
ANIP
ANI Pharmaceuticals
|
11/06/2018 | 10-Q | 10-Q filing on 11/06/2018 | View Form |
|
ANIP
ANI Pharmaceuticals
|
08/07/2018 | 10-Q | 10-Q filing on 08/07/2018 | View Form |
|
ANIP
ANI Pharmaceuticals
|
05/08/2018 | 10-Q | 10-Q filing on 05/08/2018 | View Form |
|
ANIP
ANI Pharmaceuticals
|
02/27/2018 | 10-K | 10-K filing on 02/27/2018 | View Form |
|
ANIP
ANI Pharmaceuticals
|
11/02/2017 | 10-Q | 10-Q filing on 11/02/2017 | View Form |
|
ANIP
ANI Pharmaceuticals
|
08/03/2017 | 10-Q | 10-Q filing on 08/03/2017 | View Form |
|
ANIP
ANI Pharmaceuticals
|
05/04/2017 | 10-Q | 10-Q filing on 05/04/2017 | View Form |
|
ANIP
ANI Pharmaceuticals
|
03/02/2017 | 10-K | 10-K filing on 03/02/2017 | View Form |
|
ANIP
ANI Pharmaceuticals
|
11/03/2016 | 10-Q | 10-Q filing on 11/03/2016 | View Form |
|
ANIP
ANI Pharmaceuticals
|
08/04/2016 | 10-Q | 10-Q filing on 08/04/2016 | View Form |
|
ANIP
ANI Pharmaceuticals
|
05/05/2016 | 10-Q | 10-Q filing on 05/05/2016 | View Form |
|
ANIP
ANI Pharmaceuticals
|
02/23/2016 | 10-K | 10-K filing on 02/23/2016 | View Form |
|
ANIP
ANI Pharmaceuticals
|
11/03/2015 | 10-Q | 10-Q filing on 11/03/2015 | View Form |
|
ANIP
ANI Pharmaceuticals
|
08/04/2015 | 10-Q | 10-Q filing on 08/04/2015 | View Form |
|
ANIP
ANI Pharmaceuticals
|
05/05/2015 | 10-Q | 10-Q filing on 05/05/2015 | View Form |
|
ANIP
ANI Pharmaceuticals
|
02/23/2015 | 10-K | 10-K filing on 02/23/2015 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
